Increased risk of endometrial carcinoma among users of conjugated estrogens
about
The breast cancer epidemic: 10 factsOccupational exposure to zeranol, an animal growth promoterHormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone therapy in postmenopausal women and risk of endometrial hyperplasiaDoes sexual dimorphism in human faces signal health?Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literatureSecondary solid cancer screening following hematopoietic cell transplantationMolecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative studyReproductive and hormonal risk factors of breast cancer: a historical perspective.Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceMedroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.That oestrogen replacement for osteoporosis prevention should no longer be a bone of contentionBone demineralisation in patients with Turner's syndrome.Novel oestrogen receptor β-selective ligand reduces obesity and depressive-like behaviour in ovariectomized mice.Treatment of the menopause: the swinging pendulum.Progress in gynecologic cancer detection and treatment.Estrogen therapy in postmenopausal womenBody size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort.Hip fracture, skeletal fragility, osteoporosis and hormonal deprivation in elderly women.Serum proteomic profile analysis for endometrial carcinoma detection with MALDI-TOF MSTrends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010.Hormone replacement therapy and the endometrium.Association between diabetes, diabetes treatment and risk of developing endometrial cancer.Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation.Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapyHormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives.Design and conduct of clinical trials in hormone replacement therapy.Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981.Detection of drug-induced diseaseSelective estrogen receptor modulators: tissue selectivity and differential uterine effects.Age factors potentiating drug toxicity in the reproductive axis.Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs.Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models
P2860
Q22299214-985115AB-8B98-4CFB-92A4-5A62AFDF4E2FQ23922606-36CCB2B3-8683-4B8E-8EF1-6F23E7B5B6FFQ24201543-1341F807-C7D8-47E8-84E5-512FD08B36FFQ24241713-C1B41ED9-9EEA-427C-8C91-73B979CC6291Q24673142-55E08C40-6F62-47D7-B6A7-F6D21B9058CAQ24798493-C14445A0-A7D8-44F9-ADD1-208065B3459BQ28088369-221F85A3-08AB-40FA-BE62-535F0813D421Q28249558-CDA57BC2-8C25-4198-9C48-9A6F5E0B35CCQ30234506-F557F52F-A734-4F96-8860-D5AAFBE22A58Q30380010-4F18E30F-E1B5-4E08-A4EC-346346352562Q30465714-12215DD3-9C41-47DD-81D9-65CA328F5606Q30659580-1E09C7ED-5C29-4912-BD6D-0488B81F31CBQ33565228-E15D3D7A-5A02-473A-ADB3-68115E3FD871Q33669417-E6D2CE96-94EE-4739-BFD1-2DADCE8FC1C1Q33875276-BE7457D8-BA1D-4B95-8BC1-36031467DE9BQ33876807-54786D57-A046-465E-9657-E2FF12A03E14Q33960335-CAA43C4B-D59D-4E03-833A-787E673BF17AQ34050683-A31508A8-FC0B-4B8B-9896-32E8BBC6CC19Q34078827-8AB0FBC4-C4B3-45F6-A584-719E6DFB615DQ34108842-C70AEB54-43A6-468C-B279-764502E39297Q34174681-D6BDC1F8-2A4B-4B65-942C-CC272A730758Q34232032-682E1D0D-1F7B-46D9-B61B-C36CF21A1FB8Q34263283-71840A50-1282-4DBF-863D-84FB0FC449B6Q34283665-DECFAE37-4EBB-40F7-A1AF-E74620D99F33Q34305296-6CF7D28F-E12B-4C73-971E-FB5573DC5332Q34315478-134E3387-BEE6-4C12-9072-04D619A56ECEQ34362281-760F2D5A-0999-48A4-B597-AEBDD5B9D4F8Q34369657-B3FD54EA-00EA-4F9D-8F0F-851A340BC532Q34370222-55AA10D9-F54F-495F-8CE3-877E8D297475Q34397284-5EA82431-0324-41EC-A532-808A8243657CQ34397332-B1138EFD-13B5-4C49-A2D9-7A63A6CF24CCQ34506823-F9926EFC-AF4E-45E0-8ACF-4D60B82C431EQ34517425-575033ED-9E6C-46D4-AD7F-FAD730D79E75Q34575198-8DAEFB21-71F4-4536-BFA5-A59EC9B8F5D7Q34659171-834872A1-E185-44A9-9BAE-1B7DC3D249DAQ34675156-BF43174B-9AAB-4377-8DF3-3E7D86490586Q34714606-FC8D817D-E765-4760-81EE-DA1EE671FA6AQ34759968-F38254F0-2EF0-41F5-845D-513AF174643DQ35040736-0D7653EC-0F2F-45D1-B41E-912E7DA89869Q35078498-BDB1E8D5-4BE9-40E2-8479-110BC6247B2F
P2860
Increased risk of endometrial carcinoma among users of conjugated estrogens
description
1975 nî lūn-bûn
@nan
1975 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Increased risk of endometrial carcinoma among users of conjugated estrogens
@ast
Increased risk of endometrial carcinoma among users of conjugated estrogens
@en
Increased risk of endometrial carcinoma among users of conjugated estrogens
@nl
type
label
Increased risk of endometrial carcinoma among users of conjugated estrogens
@ast
Increased risk of endometrial carcinoma among users of conjugated estrogens
@en
Increased risk of endometrial carcinoma among users of conjugated estrogens
@nl
prefLabel
Increased risk of endometrial carcinoma among users of conjugated estrogens
@ast
Increased risk of endometrial carcinoma among users of conjugated estrogens
@en
Increased risk of endometrial carcinoma among users of conjugated estrogens
@nl
P1476
Increased risk of endometrial carcinoma among users of conjugated estrogens
@en
P2093
P304
P356
10.1056/NEJM197512042932303
P407
P577
1975-12-04T00:00:00Z